Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

By afschroeder • August 7, 2025

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening - The VICTORION-PLAQUE primary prevention trial. Am Heart J. 2025 Aug 4:S0002-8703(25)00291-1. doi: 10.1016/j.ahj.2025.08.001. Epub ahead of print. PMID: 40769373.

Tags: Cardiology/Epi, CCTA derived Fractional Flow Reserve (FFR(CT)), coronary computed tomography angiography (CCTA), CT-adapted Leaman score, Harbor UCLA, Inclisiran, Low density Lipoprotein Cholesterol (LDL-C), non-obstructive coronary artery disease (NOCAD), Publications, total atheroma volume (TAV)

Advances in HIV-associated pulmonary diseases: an official American Thoracic Society workshop report

North CM, Konstantinidis I, Attia EF, Auld SC, Cho JL, Crothers K, Ferrand RA, Hsue P, Hu X, Huang L, Kaner RJ, Kunisaki KM, Leung[...]

Pulmonary Embolism: Building a Multidisciplinary Roadmap for Contemporary Care

Horowitz JM, Moriarty JM, West FM, Yuriditsky E. Pulmonary Embolism: Building a Multidisciplinary Roadmap for Contemporary Care. Clin Chest Med. 2026 Dec;47(4):xiii-xiv. doi: 10.1016/j.ccm.2026.09.001. Epub[...]

2026 SNMMI Highlights Lecture: Cardiovascular Sciences

Packard RRS. 2026 SNMMI Highlights Lecture: Cardiovascular Sciences. J Nucl Med. 2026 Nov 2;67(11):1705-1710. doi: 10.2967/jnumed.126.273334. PMID: 42595492.